Evidence for a central mechanism of obesity in the Zucker rat: Role of neuropeptide Y and leptin

Proceedings of the Society for Experimental Biology and Medicine

Volumn 214, Issue 3, 1997, Pages 222-232

  White, B Douglas ^a   Martin, Roy J ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; INSULIN; LEPTIN; NEUROPEPTIDE Y;

ANIMAL MODEL; EXPERIMENTAL MODEL; GENE MUTATION; HORMONAL REGULATION; HORMONE ACTION; NONHUMAN; OBESITY; PATHOGENESIS; RAT; REVIEW;

EID: 0030977881     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-214-44090     Document Type: Review

References (135)

1. Martin RJ, Harris RBS, Jones DD. Evidence for a central mechanism of obesity in the Zucker fatty rat (fa/fa) Proc Soc Exp Biol Med 183:1-10, 1986.
2. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659-660, 1982.
3. Chronwall BM, Di Maggio DA, Massari VJ, Pickel VM, Ruggiero DA, O'Donohue TL. The anatomy of neuropeptide Y containing neurons in the rat brain. J Neurosci 15:1159-1181, 1985.
4. Lungdberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom S, Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116:479-480, 1982.
5. Larhammer D, Soderberg C, Blomquist AG. Evolution of the Neuropeptide Y family of peptides. In: Colmers WF, Wahlestedt C, Eds. The Biology of Neuropeptide Y and Related Peptides. Totowa: Humana Press, pp. 1-41, 1993.
6. Allen JM, Balbi D. Structure and expression of the neuropeptide Y gene. In: Colmers WF, Wahlestedt C, Eds. The Biology of Neuropeptide Y and Related Peptides. Totowa: Humana Press, pp 43-64, 1993.
7. Lehmann J. Neuropeptide Y: An overview. Drug Dev Res 19:329-351, 1990.
8. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429, 1984.
9. Levine AS, Morley JE. Neuropeptide Y: A potent inducer of consummatory behavior in rats. Peptides 5:1025-1029, 1984.
10. Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hypothalamus: A powerful stimulant of feeding behavior. Proc Natl Acad Sci USA 82:3940-3943, 1984.
11. Morley JE, Levine AS, Gosnell BA, Kneip J, Grace M. Effect of neuropeptide Y on ingestive behaviors in the rat. Am J Physiol 252:R599-R609, 1987.
12. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:1189-1192, 1986.
13. Beck B, Stricker-Krongrad A, Nicolas JP, Burlet C. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behavior of obese Zucker rats. Int J Obes Relat Metab Disord 16:295-302, 1992.
14. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 260:R321-R327, 1991.
15. Egawa M, Yoshimatsu H, Bray GA. Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular adipose tissue. Neuroscience 34:771-775, 1990.
16. Zucker LM. Some effects of caloric restriction and deprivation on the obese hyperlipemic rat. J Nutr 91:247-254, 1967.
17. Bazin R, Eteve D, Lavau M. Evidence for decreased GDP binding to brown-adipose-tissue mitochondria of obese Zucker (fa/fa) rats in the very first days of life. Biochem J 221:241-245, 1984.
18. York DA, Marchington D, Holt SJ, Allars J. Regulation of sympathetic activity in lean and obese Zucker (fa/fa) rats. Am J Physiol 249:E299-E305, 1985.
19. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133:1753-1758, 1993.
20. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43:764-769, 1994.
21. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37:1202-1208, 1994.
22. Moltz JH, McDonald JK. Neuropeptide Y: Direct and indirect action on insulin secretion in the rats. Peptides 6:1155-1159, 1985.
23. Kuenzel WJ, McMurtry J. Neuropeptide Y: Brain localization and central effects on plasma insulin levels in chicks. Physiol Behav 44:669-678, 1988.
24. Abe M, Saito M, Shimazu T. Neuropeptide Y and norepinephrine injected into the paraventricular nucleus of the hypothalamus activate endocrine pancreas. Biomed Res 10:431-436, 1989.
25. Harfstrand A, Eneroth P, Agnati L, Fuxe K. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines. Regul Pept 17:167-169, 1987.
26. Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, Hakaanson R. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res 417:33-38, 1987.
27. Zucker LM, Antoniades HN. Insulin and obesity in the Zucker genetically obese rat "fatty." Endocrinology 90:1320-1330, 1972.
28. Martin RJ, Wangsness, PJ, Gahagan JH. Diurnal changes in serum metabolites and hormones in lean and obese Zucker rats. Horm Metab Res 10:187-192, 1978.
29. Opara EC, Burch WM, Taylor IL, Akwari OE. Pancreatic hormone response to neuropeptide Y (NPY) perifusion in vitro. Regul Pept 34:225-233, 1991.
30. Haas DA, George SR. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: Lack of effect in other rat brain regions. Life Sci 41:2725-2731, 1987.
31. Suda T, Tozawa F, Iwai I, Sato Y, Sumitomo T, Nakano Y, Yamada M, Demura H. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Mol Brain Res 18:311-315, 1993.
32. Inoue T, Inui A, Okita M, Sakatani N, Oya M, Marioka H, Mizuno N, Oimosi M, Baba S. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog. Life Sci 44:1043-1051, 1989.
33. Clark JT, Kalra PS, Kalra SP. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117:2435-2442, 1985.
34. Poggioli R, Vergoni A-V, Marrama D, Giuliani D, Bertolini A. NPY-induced inhibition of male copulatory activity is a direct behavioural effect. Neuropeptides 16:169-172, 1990.
35. Zucker LM, Zucker TF. Fatty, a new mutation in the rat. J Hered 52:275-278, 1961.
36. Edmonds ES, Dallie SK, Withyachumnarnkul B. Reproductive system of the obese male Zucker rat. Reproductive capacity, artifical insemination and plasma testosterone levels. Biol Reprod 27:891-897, 1982.
37. Fukagawa K, Sakata T, Yoshimatsu H, Fujimoto K, Shiraishi T. Disruption of light-dark cycle of feeding and drinking behavior, and ambulatory activity induced by development of obesity in the Zucker rat. Int J Obes 12:481-490, 1988.
38. Fukagawa K, Sakata T, Yoshimatsu H, Fujimoto K, Uchimura K, Asano C. Advance shift of feeding circadian rhythm induced by obesity progression in Zucker rats. Am J Physiol 263:R1169-R1175, 1992.
39. Jhanwar-Uniyal M, Beck B, Burlet C, Leibowitz SF. Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites. Brain Res 536:331-334, 1990.
40. Calza L, Giardino L, Zanni M, Velardo A, Parchi P, Marrama P. Daily changes of neuropeptide Y-like immunoreactivity in the suprachiasmatic nucleus of the rat. Regul Pept 27:127-137, 1990.
41. Shinohara K, Tominaga K, Isobe Y, Inouye S-IT. Photic regulation of peptides located in the ventrolateral subdivision of the suprachiasmatic nucleus of the rat: Daily variations of vasoactive intestinal polypeptide, gastrin-releasing peptide and neuropeptide Y. J Neurosci 13:793-800, 1993.
42. Biello SM, Janik D, Mrosovsky N. Neuropeptide Y and behaviorally induced phase shifts. Neuroscience 62:273-279, 1994.
43. Mrosovsky N. A non-photic gateway to the circadian clock of hamsters. Ciba Found Symp 183:154-174, 1995.
44. Huhman KL, Albers HE. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness. Peptides 15:1475-1478, 1994.
45. Albers HE, Ferris CF. Neuropeptide Y: Role in light-dark cycle entrainment of hamster circadian rhythms. Neurosci Lett 50:163-168, 1984.
46. Beck B, Burlet A, Nicolas JP, Burlet C. Hyperphagia in obesity is associated with a central peptidergic dysregulation in rats. J Nutr 120:806-811, 1990.
47. Beck B, Burlet A, Nicolas JP, Burlett C. Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: Implications in feeding and sexual behaviors. Physiol Behav 47:449-453, 1990.
48. McKibbin PE, Cotton SJ, McMillan S, Holloway B, Mayers R, McCarthy HD, Williams G. Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Possible relationship to obesity and neuroendocrine disturbances. Diabetes 40:1423-1429, 1991.
49. Beck B, Burlet A, Bazin R, Nicolas JP, Burlet C. Early modification of neuropeptide Y but not of neurotensin in the suprachiasmatic nucleus of the obese Zucker rat. Neurosci Lett 136:185-188, 1992.
50. Beck B, Burlet A, Bazin R, Nicolas JP, Burlet C. Elevated neuropeptide Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating. J Nutr 123:1168-1172, 1993.
51. Boulange A, Planche E, de Gasquet P. Onset of genetic obesity in the absence of hyperphagia during the first week of life in the Zucker rat (fa/fa). J Lipid Res 20:857-864, 1979.
52. Godbole VY, Grundleger ML, Pasquine TA, Thenen SW. Composition of rat milk from day 5 to 20 of lactation and milk intake of lean and preobese Zucker pups. J Nutr 111:480-487, 1981.
53. Sanacora G, Kershaw M, Finkelstein JA, White JD. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127:730-737, 1990.
54. Pesonen U, Rouru J, Huupponen R, Koulu M. Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats. Mol Brain Res 10:267-272, 1991.
55. Pesonen U, Huupponen R, Rouru J, Koulu M. Hypothalamic neuropeptide expression after food restriction in Zucker rats: Evidence of persistent neuropeptide Y gene activation. Mol Brain Res 16:255-260, 1992.
56. Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF, Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res 331:172-175, 1985.
57. Jhanwar-Uniyal M, Chua SC Jr. Critical effects of aging and nutritional state on hypothalamic neuropeptide Y and galanin gene expression in lean and genetically obese Zucker rats. Mol Brain Res 19:195-202, 1993.
58. Sanacora G, Finkelstein JA, White JD. Developmental aspect of differences in hypothalamic preproneuropeptide Y messenger ribonucleic acid content in lean and genetically obese Zucker rats. J Neuroendocrinol 4:353-357, 1992.
59. Chung WK, Truett GE, Smoller JW, Hirsch J, Leibel R. Increased hypothalamic preproneuropeptide Y mRNA in six to nine day old fatty (fa/fa) rats. (abstract) FASB J 6:A1785, 1992.
60. Brief DJ, Sipols AJ, Woods SC. Intraventricular neuropeptide Y injections stimulate food intake in lean, but not obese Zucker rats. Physiol Behav 51:1105-1110, 1992.
61. McCarthy HD, McKibbin PE, Holloway B, Mayers R, Williams G. Hypothalamic neuropeptide Y receptor characteristics and NPY-induced feeding responses in lean and obese Zucker rats. Life Sci 49:1491-1497, 1991.
62. Stricker-Krongrad A, Max JP, Musse N, Nicolas JP, Burlet C, Beck B. Increased threshold concentrations of neuropeptide Y for a stimulatory effect on food intake in obese Zucker rats - changes in the microstructure of the feeding behavior. Brain Res 660:162-166, 1994.
63. Hervey GR. The effects of lesions in the hypothalamus of parabiotic rats. J Physiol 145:336-352, 1959.
64. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141-148, 1978.
65. Coleman DL, Hummel KP. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 217:1298-1304, 1969.
66. Hausberger FX. Parabiosis and transplantation experiments in hereditarily obese mice. (abstract) Anat Rec 130:313, 1958.
67. Haessler HA, Crawford JD. Alterations in the fatty acid composition of depot fat associated with obesity. Ann N Y Acad Sci 131:476-484, 1965.
68. Chlouverakis C. Insulin resistance of parabiotic obese-hyperglycemic mice (ob/ob). Horm Metab Res 4:143-148, 1972.
69. Coleman DL. Effects of parabiosis of obese with diabetic and normal mice. Diabetologia 9:294-298, 1973.
70. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994.
71. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995.
72. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995.
73. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995.
74. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96:2065-2070, 1995.
75. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J. Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR Jr., Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530-532, 1995.
76. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311, 1996.
77. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995.
78. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Med 1:1311-1314, 1995.
79. Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med 1:950-953, 1995.
80. Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1:953-956, 1995.
81. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271, 1995.
82. Lee G-H, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635, 1996.
83. Streamson CC Jr., Chung WK, Wu-Peng XS, Zhang Y, Liu S-M, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (Leptin) receptor. Science 271:994-996, 1996.
84. Harris RBS, Hervey E, Hervey GR, Tobin G. Body composition of lean and obese Zucker rats in parabiosis. Int J Obes 11:275-283, 1987.
85. Moinat M, Deng C, Muzzin P, Assimacopoulos-Jeannet F, Seydoux J, Dulloo AG, Giacobino J-P. Modulation of obese gene expression in rat brown and white adipose tissues. FEBS Lett 373:131-134, 1995.
86. Truett GE, Bahary N, Friedman JM, and Leibel RL. Rat obesity gene fatty (fa) maps to chromosome 5: Evidence for homology with the mouse gene diabetes (db). Proc Natl Acad Sci U S A 88:7806-7809, 1991.
87. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CT, Hess JF. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13:18-19, 1996.
88. Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M, Shima K. Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun 222:19-26, 1996.
89. Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, Ghatei MA, Bloom SR. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132:1939-1944, 1993.
90. Chua SC, Brown AW, Kim J, Hennessey KL, Leibel RL, Hirsch J. Food deprivation and hypothalamic neuropeptide gene expression: Effects of strain background and the diabetes mutation. Mol Brain Res 11:291-299, 1991.
91. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ ob mice. Diabetes 45:531-535, 1996.
92. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. nature 381:415-418, 1996.
93. Yukimura Y, Bray GA, Wolfsen AR. Some effects of adrenalectomy in the fatty rat. Endocrinology 103:1924-1928, 1978.
94. Fletcher JM. Effects of adrenalectomy before weaning in the genetically obese Zucker rat (fa/fa). Br J Nutr 56:141-151, 1986.
95. Freedman MR, Horwitz BA, Stern JS. Effects of adrenalectomy and glucocorticoid replacement on development of obesity. Am J Physiol 250:R595-R607, 1986.
96. Kalra SP, Dube MG, Kalra PS. Continuous intraventricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: Effects of adrenalectomy and cholecystokinin. Peptides 9:723-728, 1988.
97. Stanley BG, Lanthier D, Chin AS, Leibowitz SF. Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: Reversal with corticosterone. Brain Res 501:32-36, 1989.
98. Eva C, Oberto A, Sprengel R, Genazzani E. The murine NPY-1 receptor gene. Structure and delineation of tissue-specific expression. FEBS Lett 314:285-288, 1992.
99. Larson PJ, Jessop DS, Chowdrey HS, Lightman SL, Mikkelsen JD. Chronic administration of glucocorticoids directly upregulates prepro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J Neuroendocrinol 6:153-159, 1994.
100. Akabayashi A, Watanabe Y, Wahlestedt C, McEwen BS, Paez X, Leibowitz SF. Hypothalamic neuropeptide Y, its gene expression and receptor activity: Relation to circulating corticosterone in adrenalectomized rats. Brain Res 665:201-212, 1994.
101. Heinrichs SC, Menzaghi F, Pich EM, Hauger RL, Koob GF. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res 611:18-24, 1993.
102. Menzaghi F, Heinrichs SC, Pich EM, Tilders FJH, Koobs GF. Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y. Brain Res 618:76-82, 1993.
103. Harfstrand A, Cintra A, Fuxe K, Aronsson M, Wikstrom AC, Okret S, Gustafsson JA, Agnati LF. Regional differences in glucorticoid receptor immunoreactivity among neuropeptide Y immunoreactive neurons of the rat brain. Acta Physiol Scand 135:3-9, 1989.
104. Ceccatelli S, Cintra A, Hokfelt T, Fuxe K, Wikstrom AC, Gustafsson JA. Coexistence of glucocorticoid receptor-like immunoreactivity with neuropeptides in the hypothalamic paraventricular nucleus. Exp Brain Res 78:33-42, 1989.
105. Higuchi H, Yang HY, Sabol SL. Rat neuropeptide Y precursor gene expression, mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester. J Biol Chem 263:6288-6295, 1988.
106. Barnea A, Cho G, Hajibeigi A, Aguila MC, Magni P. Dexamethasone-induced accumulation of neuropeptide-Y by aggregating fetal brain cells in culture: A process dependent on the developmental age of the aggregates. Endocrinology 129:931-938, 1991.
107. Corder R, Pralong F, Turnill D, Saudan P, Muller AF, Gaillard RC. Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neurones. Life Sci 43:1879-1886, 1988.
108. McKibbin PE, Cotton SJ, McCarthy HD, Williams G. The effect of dexamethasone on neuropeptide Y concentrations in specific hypothalamic regions. Life Sci 51:1301-1307, 1992.
109. Wilding JPH, Gilbey SG, Lambert PD, Ghatei MA, Bloom SR. Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin. Neuroendocrinology 57:581-587, 1993.
110. Pralong FP, Corder R, Gaillard RC. The effects of chronic glucocorticoid excess, adrenalectomy and stress on neuropeptide Y in individual rat hypothalamic nuclei. Neuropeptides 25:223-231, 1993.
111. White BD, Dean RG, Martin RJ. Adrenalectomy decreases neuropeptide Y mRNA levels in the arcuate nucleus. Brain Res Bull 25:711-715, 1990.
112. Watanabe Y, Akabayashi A, McEwen BS. Adrenal steroid regulation on neuropeptide Y (NPY) mRNA: differences between dentate hilus and locus coeruleus and arcuate nucleus. Mol Brain Res 28:135-140, 1995.
113. White BD, Dean RG, Edwards GL, Martin RJ. Type II corticosticoid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats. Am J Physiol 266:R1523-R1529, 1994.
114. Misaki N, Higuchi H, Yamagata K, Miki N. Identification of glucocorticoid responsive elements (GREs) at far upstream of rat NPY gene. Neurochem Int 21:185-189, 1992.
115. van Huijsduijnen OB-H, Rohner-Jeanrenaud F, Jeanrenaud B. Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats: Potential regulation thereof by corticotropin-releasing factor. J Neuroendocrinol 5:381-386, 1993.
116. Tempel DL, Leibowitz SF. Glucocorticoid receptors in PVN: Interactions with NE, NPY, and Gal in relation to feeding. Am J Physiol 26S:E794-E800, 1993.
117. Langley SC, York DA. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats. Am J Physiol 259:R539-R544, 1990.
118. Fletcher JM, Haggary P, Wahle KWJ, Reeds RJ. Hormonal studies of young lean and obese Zucker rats. Horm Metab Res 18:290-295, 1986.
119. Guillaume-Gentil C, Rohner-Jeanrenaud F, Abramo F, Bestetti GE, Rossi GL, Jeanrenaud B. Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat. Endocrinology 126:1873-1879, 1990.
120. Williams G, Steel JH, Cardoso H, Ghatei MA, Lee YC, Gill JS, Burrin JM, Polak JM, Bloom SR. Increased hypothalamic neuropeptide Y concentration in diabetic rats. Diabetes 37:763-772, 1988.
121. Williams G, Gill JS, Lee YC, Cardoso HM, Okpere BE, Bloom SR. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozotocin-induced diabetic rats. Diabetes 38:321-327, 1989.
122. Sahu A, Sninsky CA, Kalra PS, Kalra SP. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 126:192-198, 1990.
123. Abe M, Saito M, Ikeda H, Shimazu T. Increased neuropeptide Y content in the arcuato-paraventricular hypothalamic neuronal system in both insulin-dependent and non-insulin-dependent diabetic rats. Brain Res 539:223-227, 1991.
124. Sahu A, Sninsky CA, Phelps CP, Dube MG, Kalra PS, Kalra SP. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 131:2979-2985, 1992.
125. White JD, Olchovsky D, Kershaw M, Berelowitz M. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 126:765-772, 1990b.
126. Schwartz MW, Marks JL, Sipols AJ, Baskin DG, Woods SC, Kahn SE, Porte D Jr. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 128:2645-2647, 1991.
127. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP, Porte D Jr. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130:3608-3616, 1992.
128. Ponsalle P, Srivastava LS, Uht RM, White JD. Glucocorticoids are required for food deprivation-induced increases in hypothalamic neuropeptide Y expression. J Neuroendocrinol 4:585-591, 1992.
129. Cusin I, Dryden S, Wang Q, Rohner-Jeanrenaud F, Jeanrenaud B, Williams G. Effect of sustained physiological hyperinsulinaemia on hypothalamic neuropeptide Y and NPY mRNA levels in the rat. J Neuroendocrinol 7:193-197, 1995.
130. Akabayashi A, Zaia CTBV, Silva I, Chae HJ, Leibowitz SF. Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization. Brain Res 621:343-348, 1993.
131. He B, White BD, Edwards GL, Martin RJ. 2-Deoxy-D-glucose and NPY gene expression in the arcuate nucleus and specific brainstem nuclei in the rat. (abstract) FASEB J 9:A582, 1995.
132. Figlewicz DP, Dorsa DM, Stein LJ, Baskin DG, Paquette T, Greenwood MRC, Woods SC, Porte D Jr. Brain and insulin liver binding is decreased in Zucker rats carrying the "fa" gene. Endocrinology 117:1537-1543, 1985.
133. Ikeda H, Nishikawa K, Matsuo T. Feeding responses of Zucker rats to 2-deoxy-D-glucose, norepinephrine, and insulin. Am J Physiol 239:E379-E384, 1980.
134. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, Smith M. Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14:303-347, 1993.
135. Strack AM, Sebastian RJ, Schwartz MW, Dallman MF. Glucocorticoids and insulin: Reciprocal signals for energy balance. Am J Physiol 268:R142-R149, 1995.